BC Centre for Excellence in HIV/AIDS

BC-CfE Interim Recommendations for COVID-19 and Persons with HIV

Recommendations for the prevention, diagnosis, management and treatment of COVID-19 in people with HIV are the same as those for the general population [1]. The available data about the incidence and course of COVID-19 disease in persons with HIV continues to evolve. However, some people with HIV have comorbidities (e.g., cardiovascular disease, lung disease, diabetes mellitus, obesity) that are known to be associated with an increased risk of more severe COVID-19 illness.

Read More

BC-CfE CDET Statement on the use of COVID-19 vaccines in Persons Living with HIV

People living with HIV (PLWH) aged 18 years or older should be vaccinated for COVID-19 if they meet current Public Health criteria for priority groups and if they have no contraindications (see below). These vaccines are not expected to be associated with more serious or different adverse events among PLWH or other immunocompromised individuals.

Read More

Lab Test Alert

Serum Creatinine lab test results reported by some BC laboratories November 2020 to March 2021 may be higher than expected.

Read More